MoneyWorks4Me

Lincoln Pharmaceuticals informs about press release

16 Sep 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that it enclosed a Press Release on 16th September 2021 titled ‘National Company Law Tribunal approves scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..